Markus M. Lerch

Markus M. Lerch, MD FRCP, is Professor of Medicine, Physician-in-Chief and Chief Operating Officer at LMU University Hospital Munich, one of Europe’s premier academic medical centres. Since 2021 he has led clinical, educational and research activities of this 2 200-bed institution while continuing a prolific personal research programme. Prior to Munich he served from 2007-2020 as Professor and Chair of the Department of Medicine A at University Medicine Greifswald, preceded by professorial and senior consultant roles at the Universities of Münster, Homburg/Saar, Ulm, and Harvard Medical School.

Education & Training
His formative training began with undergraduate studies in Philosophy and Art History before he read medicine in Freiburg, Glasgow, Toronto and at the University of Massachusetts, earning his MD in 1984. Post-doctoral fellowships followed at Beth Israel Hospital & Harvard Medical School and the Università degli Studi di Milano, after which he obtained his German Habilitation (D.Sc. equivalent) from Ulm University in 1992 and board certifications in Gastroenterology and in Biochemistry.

Research Interests
His laboratory focuses on the pathophysiology, cell biology and genetics of pancreatic disorders. Landmark contributions include:

• identification of the pancreatic acinar cell as the primary injury site in pancreatitis,
• discovery of transient pancreatic duct obstruction and missorted endocytosis as initiating events in gallstone pancreatitis,
• elucidation of calcium-mediated protease activation and lysosomal enzyme involvement,
• demonstration of magnesium’s ability to block trypsin activation (now in clinical trials),
• characterisation of immune-cell (macrophage/NLRP3 inflammasome) roles in onset and severity of pancreatitis,
• genetic risk stratification (ABO-B, FUT2) and metabolomic biomarker signatures distinguishing pancreatitis from cancer,
• establishment of the exocrine pancreas as a key regulator of intestinal microbiota.

These studies remain deliberately translational, bridging bench to bedside.

Scientific Recognition
Professor Lerch’s work has been honoured with numerous international awards, including:

• American Pancreatic Association Lifetime Achievement Award (2021)
• George-Palade-Prize in Cell Biology (2018)
• Lifetime Achievement Award of the European Pancreatic Club (2016)
• Elected Member of Academia Europaea (2016)
• Honorary Fellow of the Royal College of Physicians and Surgeons of Glasgow (2001)
• and many named lectureships and honorary memberships worldwide.

Leadership & Service
Beyond his institutional roles he has been:

• President of the German Gastroenterological Society (DGVS, 2011-2017)
• President of the German Society of Internal Medicine (DGIM, 2021-2022)
• Secretary and later President of the European Pancreatic Club
• Associate Editor of Gut and editorial board member of leading journals
• Member of the German National Council of Science and Humanities (Wissenschaftsrat), appointed by the Federal President.

His laboratory continues to be continuously funded, translating mechanistic insights into improved diagnostics and therapies for patients with pancreatic diseases.